Studies Suggest Similar Risks for Biologics vs. Conventional Therapies for Rheumatoid Arthritis
Baricitinib Studied as Possible COVID-19 Treatment; Plus Ranitidine Removed from U.S. Market
U.S. FDA Warns Against Using Hydroxychloroquine for COVID-19
Yes, the FDA Employs Rheumatologists. Here’s Their Role.
FDA Update: New Drug Approvals, New & Expanded Indications, & More
How to Address Opioid Abuse with Patients
FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin
How to Improve Opioid Prescribing in an Outpatient Clinic
Measles Is Back. How Does This Affect Patients with Rheumatic Disease?
- 1
- 2
- 3
- …
- 17
- Next Page »